Target Name: IL21R
NCBI ID: G50615
Review Report on IL21R Target / Biomarker Content of Review Report on IL21R Target / Biomarker
IL21R
Other Name(s): NILR | novel interleukin receptor | IL-21 receptor | Interleukin-21 receptor (isoform 1) | Novel interleukin receptor | IL21R_HUMAN | interleukin 21 receptor | IL-21R | Interleukin 21 receptor, transcript variant 3 | CD360 | IMD56 | Interleukin-21 receptor (isoform 2) | Interleukin-21 receptor subunit | IL21R variant 3 | Interleukin-21 receptor | Interleukin 21 receptor, transcript variant 2 | IL21R variant 2

IL21R: Unlocking The Potential of A Drug Target

IL21R (Interleukin-21 receptor) is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and nervous system. It is a member of the IL-21 receptor family, which is a subset of the IL -1 cytokine receptor family. IL-1 cytokines are involved in the regulation of immune and inflammatory responses, and the IL-21 receptor plays a role in the regulation of these processes.

IL21R has been shown to be involved in a number of different biological processes, including the regulation of immune cell function, the development and progression of skin diseases, and the regulation of pain. It is also been shown to be involved in the regulation of inflammation , as well as the regulation of cell growth and differentiation.

Despite the fact that IL21R has been studied extensively, it is still not well understood. The exact function of IL21R is not yet known, and it is not clear exactly how it interacts with other proteins. However, studies have shown that IL21R plays a role in the regulation of a wide range of biological processes, including immune cell function, skin development and regulation, inflammation, and cell growth and differentiation.

One potential drug target for IL21R is the use of small molecules that can modulate its activity. For example, researchers have shown that inhibitors of the IL-1 receptor, which is a related protein, can be effective in reducing the activity of IL21R. Additionally , researchers have shown that inhibitors of the IL-6 receptor, which is another protein that is involved in the regulation of inflammation, can also be effective in reducing the activity of IL21R.

Another potential drug target for IL21R is the use of antibodies that can specifically bind to and inhibit its activity. Researchers have shown that antibodies against IL21R have the potential to be effective in treating a wide range of diseases, including skin diseases and autoimmune disorders.

While further research is needed to fully understand the function of IL21R and its potential as a drug target, it is clear that this protein plays an important role in the regulation of a wide range of biological processes. and the potential for its use as a drug.

Protein Name: Interleukin 21 Receptor

Functions: This is a receptor for interleukin-21

The "IL21R Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL21R comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R | IL6R-AS1 | IL6ST | IL6ST-DT | IL6STP1 | IL7 | IL7R | IL9 | IL9R | IL9RP3 | IL9RP4 | ILDR1 | ILDR2 | ILF2 | ILF3 | ILF3-DT | ILK | ILKAP | ILRUN | ILVBL | Imidazoline I2 receptor (I2) | Imidazoline I3 receptor (I3) | Imidazoline receptor | IMMP1L | IMMP2L | IMMT | IMMTP1 | Immunoglobulin A | Immunoglobulin E (IgE) | Immunoglobulin G | Immunoglobulin M | Immunoglobulin-Like Domain Containing Receptor | Immunoproteasome | IMP3 | IMP4 | IMPA1 | IMPA1P1 | IMPA2 | IMPACT | IMPDH1 | IMPDH1P10 | IMPDH1P6 | IMPDH2 | IMPG1 | IMPG2 | INA | INAFM1 | INAFM2 | INAVA | INCA1 | INCENP | INE1 | INE2 | INF2 | ING1 | ING2 | ING2-DT | ING3 | ING4 | ING5 | INGX | INHA | INHBA | INHBA-AS1 | INHBB | INHBC | INHBE